Global Meningitis Vaccine Market Insights, Forecast to 2025
- QYR2768911
- 119 Pages
- September 2018
- Pharmaceuticals
This research report categorizes the global Meningitis Vaccine market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.
In 2017, the global Meningitis Vaccine market size was million US$ and is forecast to million US in 2025, growing at a CAGR of from 2018. The objectives of this study are to define, segment, and project the size of the Meningitis Vaccine market based on company, product type, application and key regions.
The various contributors involved in the value chain of Meningitis Vaccine include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Meningitis Vaccine include
GlaxoSmithKline
Baxter International
Sanofi Pasteur
Merck
Novartis
Pfizer
Hualan
Zhejiang Tianyuan
Beijing Tiantan Biological
Market Size Split by Type
Meningitis A+C
Meningitis ACWY135
Meningitis B
Market Size Split by Application
Medical Care
Hospital
Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Meningitis Vaccine market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Meningitis Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Meningitis Vaccine manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Meningitis Vaccine with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Meningitis Vaccine submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Meningitis Vaccine are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Meningitis Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 Study Coverage
1.1 Meningitis Vaccine Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Meningitis Vaccine Market Size Growth Rate by Type
1.4.2 Meningitis A+C
1.4.3 Meningitis ACWY135
1.4.4 Meningitis B
1.5 Market by Application
1.5.1 Global Meningitis Vaccine Market Size Growth Rate by Application
1.5.2 Medical Care
1.5.3 Hospital
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Meningitis Vaccine Market Size
2.1.1 Global Meningitis Vaccine Revenue 2016-2025
2.1.2 Global Meningitis Vaccine Sales 2016-2025
2.2 Meningitis Vaccine Growth Rate by Regions
2.2.1 Global Meningitis Vaccine Sales by Regions
2.2.2 Global Meningitis Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Meningitis Vaccine Sales by Manufacturers
3.1.1 Meningitis Vaccine Sales by Manufacturers
3.1.2 Meningitis Vaccine Sales Market Share by Manufacturers
3.1.3 Global Meningitis Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Meningitis Vaccine Revenue by Manufacturers
3.2.1 Meningitis Vaccine Revenue by Manufacturers (2016-2018)
3.2.2 Meningitis Vaccine Revenue Share by Manufacturers (2016-2018)
3.3 Meningitis Vaccine Price by Manufacturers
3.4 Meningitis Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Meningitis Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Meningitis Vaccine Product Category
3.4.3 Date of International Manufacturers Enter into Meningitis Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Meningitis Vaccine Sales by Type
4.2 Global Meningitis Vaccine Revenue by Type
4.3 Meningitis Vaccine Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Meningitis Vaccine Breakdown Data by Application
6 North America
6.1 North America Meningitis Vaccine by Countries
6.1.1 North America Meningitis Vaccine Sales by Countries
6.1.2 North America Meningitis Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Meningitis Vaccine by Type
6.3 North America Meningitis Vaccine by Application
6.4 North America Meningitis Vaccine by Company
7 Europe
7.1 Europe Meningitis Vaccine by Countries
7.1.1 Europe Meningitis Vaccine Sales by Countries
7.1.2 Europe Meningitis Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Meningitis Vaccine by Type
7.3 Europe Meningitis Vaccine by Application
7.4 Europe Meningitis Vaccine by Company
8 Asia Pacific
8.1 Asia Pacific Meningitis Vaccine by Countries
8.1.1 Asia Pacific Meningitis Vaccine Sales by Countries
8.1.2 Asia Pacific Meningitis Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Meningitis Vaccine by Type
8.3 Asia Pacific Meningitis Vaccine by Application
8.4 Asia Pacific Meningitis Vaccine by Company
9 Central & South America
9.1 Central & South America Meningitis Vaccine by Countries
9.1.1 Central & South America Meningitis Vaccine Sales by Countries
9.1.2 Central & South America Meningitis Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Meningitis Vaccine by Type
9.3 Central & South America Meningitis Vaccine by Application
9.4 Central & South America Meningitis Vaccine by Company
10 Middle East and Africa
10.1 Middle East and Africa Meningitis Vaccine by Countries
10.1.1 Middle East and Africa Meningitis Vaccine Sales by Countries
10.1.2 Middle East and Africa Meningitis Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Meningitis Vaccine by Type
10.3 Middle East and Africa Meningitis Vaccine by Application
10.4 Middle East and Africa Meningitis Vaccine by Company
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Meningitis Vaccine
11.1.4 Meningitis Vaccine Product Description
11.1.5 Recent Development
11.2 Baxter International
11.2.1 Baxter International Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Meningitis Vaccine
11.2.4 Meningitis Vaccine Product Description
11.2.5 Recent Development
11.3 Sanofi Pasteur
11.3.1 Sanofi Pasteur Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Meningitis Vaccine
11.3.4 Meningitis Vaccine Product Description
11.3.5 Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Meningitis Vaccine
11.4.4 Meningitis Vaccine Product Description
11.4.5 Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Meningitis Vaccine
11.5.4 Meningitis Vaccine Product Description
11.5.5 Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Meningitis Vaccine
11.6.4 Meningitis Vaccine Product Description
11.6.5 Recent Development
11.7 Hualan
11.7.1 Hualan Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Meningitis Vaccine
11.7.4 Meningitis Vaccine Product Description
11.7.5 Recent Development
11.8 Zhejiang Tianyuan
11.8.1 Zhejiang Tianyuan Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Meningitis Vaccine
11.8.4 Meningitis Vaccine Product Description
11.8.5 Recent Development
11.9 Beijing Tiantan Biological
11.9.1 Beijing Tiantan Biological Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Meningitis Vaccine
11.9.4 Meningitis Vaccine Product Description
11.9.5 Recent Development
12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators
13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Meningitis Vaccine Raw Material
13.1.2 Meningitis Vaccine Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer
Figure Picture of Meningitis Vaccine
Figure Global Meningitis Vaccine Production (K MT) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Meningitis Vaccine Production Market Share by Types (Product Category) in 2017
Figure Meningitis A+C Product Picture
Table Major Manufacturers of Meningitis A+C
Figure Meningitis ACWY135 Product Picture
Table Major Manufacturers of Meningitis ACWY135
Figure Meningitis B Product Picture
Table Major Manufacturers of Meningitis B
Table Global Meningitis Vaccine Market Size Growth Rate by Application 2018-2025 (K MT)
Figure Medical Care
Figure Hospital
Figure Meningitis Vaccine Report Years Considered
Figure Global Meningitis Vaccine Market Size 2016-2025 (Million US$)
Figure Global Meningitis Vaccine Sales 2016-2025 (K MT)
Table Global Meningitis Vaccine Market Size by Regions 2016-2025 (K MT) & (Million US$)
Table Global Meningitis Vaccine Sales by Regions 2016-2025 (K MT)
Table Global Meningitis Vaccine Sales Market Share by Regions 2016-2025
Figure Global Meningitis Vaccine Sales Market Share by Regions 2016-2025
Figure 2017 Global Meningitis Vaccine Sales Market Share by Regions
Table Global Meningitis Vaccine Revenue by Regions 2016-2025 (Million US$)
Table Global Meningitis Vaccine Revenue Market Share by Regions 2016-2025
Figure Global Meningitis Vaccine Revenue Market Share by Regions 2016-2025
Figure 2017 Global Meningitis Vaccine Revenue Market Share by Regions
Table Global Meningitis Vaccine Sales by Manufacturers (2016-2018) (K MT)
Table Global Meningitis Vaccine Sales Share by Manufacturers (2016-2018)
Figure Global Meningitis Vaccine Sales Share by Manufacturers in 2017
Table Meningitis Vaccine Revenue by Manufacturers (2016-2018) (Million US$)
Table Meningitis Vaccine Revenue Share by Manufacturers (2016-2018)
Figure Meningitis Vaccine Value Share by Manufacturers in 2017
Table Global Meningitis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Meningitis Vaccine Price (2016-2018) (USD/MT)
Table Meningitis Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Meningitis Vaccine Product Category
Table Date of International Manufacturers Enter into Meningitis Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Meningitis Vaccine Sales by Type (2016-2025) (K MT)
Table Global Meningitis Vaccine Sales Share by Type (2016-2025)
Figure Global Meningitis Vaccine Sales Market Share by Type (2016-2025)
Figure Global Meningitis Vaccine Sales Market Share by Type in 2017
Table Global Meningitis Vaccine Revenue by Type (2016-2025) (Million US$)
Table Global Meningitis Vaccine Revenue Share by Type (2016-2025)
Figure Global Meningitis Vaccine Revenue Market Share by Type (2016-2025)
Figure Global Meningitis Vaccine Revenue Market Share by Type in 2017
Table Meningitis Vaccine Price by Type 2013-2018 (USD/MT)
Table Global Meningitis Vaccine Sales by Application (2016-2025) (K MT)
Table Global Meningitis Vaccine Sales Share by Application (2016-2025)
Figure Global Sales Meningitis Vaccine Market Share by Application (2016-2025)
Figure Global Sales Meningitis Vaccine Market Share by Application (2016-2025)
Figure North America Meningitis Vaccine Sales Growth Rate 2016-2025 (K MT)
Figure North America Meningitis Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table North America Meningitis Vaccine Sales by Countries (2016-2025) (K MT)
Table North America Meningitis Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 North America Meningitis Vaccine Sales Market Share by Countries
Table North America Meningitis Vaccine Revenue by Countries (2016-2025) (Million US$)
Table North America Meningitis Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Meningitis Vaccine Revenue Market Share by Countries
Figure United States Meningitis Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure United States Meningitis Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Meningitis Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Canada Meningitis Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Meningitis Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Mexico Meningitis Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table North America Meningitis Vaccine Sales by Type (2016-2025) (K MT)
Table North America Meningitis Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 North America Meningitis Vaccine Market Share by Type
Table North America Meningitis Vaccine Sales by Application (2016-2025) (K MT)
Table North America Meningitis Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 North America Meningitis Vaccine Market Share by Application
Table North America Meningitis Vaccine Sales by Company (2016-2018) (K MT)
Table North America Meningitis Vaccine Sales Market Share by Company (2016-2018)
Figure North America Meningitis Vaccine Sales Market Share by Company in 2017
Figure Europe Meningitis Vaccine Sales Growth Rate 2016-2025 (K MT)
Figure Europe Meningitis Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Meningitis Vaccine Sales by Countries (2016-2025) (K MT)
Table Europe Meningitis Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Meningitis Vaccine Sales Market Share by Countries
Table Europe Meningitis Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Europe Meningitis Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Meningitis Vaccine Revenue Market Share by Countries
Figure Germany Meningitis Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Germany Meningitis Vaccine Revenue Growth Rate (2016-2025) (K MT)
Figure France Meningitis Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure France Meningitis Vaccine Revenue Growth Rate (2016-2025) (K MT)
Figure UK Meningitis Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure UK Meningitis Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Meningitis Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Italy Meningitis Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Meningitis Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Russia Meningitis Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Meningitis Vaccine Sales by Type (2016-2025) (K MT)
Table Europe Meningitis Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Europe Meningitis Vaccine Market Share by Type
Table Europe Meningitis Vaccine Sales by Application (2016-2025) (K MT)
Table Europe Meningitis Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Europe Meningitis Vaccine Market Share by Application
Table Europe Meningitis Vaccine Sales by Company (2016-2018) (K MT)
Table Europe Meningitis Vaccine Sales Market Share by Company (2016-2018)
Figure Europe Meningitis Vaccine Sales Market Share by Company in 2017
Figure Asia Pacific Meningitis Vaccine Sales Growth Rate 2016-2025 (K MT)
Figure Asia Pacific Meningitis Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Meningitis Vaccine Sales by Countries (2016-2025) (K MT)
Table Asia Pacific Meningitis Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Meningitis Vaccine Sales Market Share by Countries
Table Asia Pacific Meningitis Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Meningitis Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Meningitis Vaccine Revenue Market Share by Countries
Figure China Meningitis Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure China Meningitis Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Meningitis Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Japan Meningitis Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Meningitis Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Korea Meningitis Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure India Meningitis Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure India Meningitis Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Meningitis Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Australia Meningitis Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Meningitis Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Indonesia Meningitis Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Meningitis Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Malaysia Meningitis Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Meningitis Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Philippines Meningitis Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Meningitis Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Thailand Meningitis Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Meningitis Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Vietnam Meningitis Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Meningitis Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Singapore Meningitis Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Meningitis Vaccine Sales by Type (2016-2025) (K MT)
Table Asia Pacific Meningitis Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Meningitis Vaccine Market Share by Type
Table Asia Pacific Meningitis Vaccine Sales by Application (2016-2025) (K MT)
Table Asia Pacific Meningitis Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Meningitis Vaccine Market Share by Application
Table Asia Pacific Meningitis Vaccine Sales by Company (2016-2018) (K MT)
Table Asia Pacific Meningitis Vaccine Sales Market Share by Company (2016-2018)
Figure Asia Pacific Meningitis Vaccine Sales Market Share by Company in 2017
Figure Central & South America Meningitis Vaccine Sales Growth Rate 2016-2025 (K MT)
Figure Central & South America Meningitis Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Meningitis Vaccine Sales by Countries (2016-2025) (K MT)
Table Central & South America Meningitis Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Meningitis Vaccine Sales Market Share by Countries
Table Central & South America Meningitis Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Meningitis Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Meningitis Vaccine Revenue Market Share by Countries
Figure Brazil Meningitis Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Brazil Meningitis Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Meningitis Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Argentina Meningitis Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Meningitis Vaccine Sales by Type (2016-2025) (K MT)
Table Central & South America Meningitis Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Meningitis Vaccine Market Share by Type
Table Central & South America Meningitis Vaccine Sales by Application (2016-2025) (K MT)
Table Central & South America Meningitis Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Meningitis Vaccine Market Share by Application
Table Central & South America Meningitis Vaccine Sales by Company (2016-2018) (K MT)
Table Central & South America Meningitis Vaccine Sales Market Share by Company (2016-2018)
Figure Central & South America Meningitis Vaccine Sales Market Share by Company in 2017
Figure Middle East and Africa Meningitis Vaccine Sales Growth Rate 2016-2025 (K MT)
Figure Middle East and Africa Meningitis Vaccine Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Meningitis Vaccine Sales by Countries (2016-2025) (K MT)
Table Middle East and Africa Meningitis Vaccine Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Meningitis Vaccine Sales Market Share by Countries
Table Middle East and Africa Meningitis Vaccine Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Meningitis Vaccine Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Meningitis Vaccine Revenue Market Share by Countries
Figure GCC Countries Meningitis Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure GCC Countries Meningitis Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Meningitis Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Turkey Meningitis Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Meningitis Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure Egypt Meningitis Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Meningitis Vaccine Sales Growth Rate (2016-2025) (K MT)
Figure South Africa Meningitis Vaccine Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Meningitis Vaccine Sales by Type (2016-2025) (K MT)
Table Middle East and Africa Meningitis Vaccine Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Meningitis Vaccine Market Share by Type
Table Middle East and Africa Meningitis Vaccine Sales by Application (2016-2025) (K MT)
Table Middle East and Africa Meningitis Vaccine Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Meningitis Vaccine Market Share by Application
Table Middle East and Africa Meningitis Vaccine Sales by Company (2016-2018) (K MT)
Table Middle East and Africa Meningitis Vaccine Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Meningitis Vaccine Sales Market Share by Company in 2017
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Meningitis Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table GlaxoSmithKline Recent Development
Table Baxter International Company Details
Table Baxter International Meningitis Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Baxter International Recent Development
Table Sanofi Pasteur Company Details
Table Sanofi Pasteur Meningitis Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Sanofi Pasteur Recent Development
Table Merck Company Details
Table Merck Meningitis Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Meningitis Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Meningitis Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Pfizer Recent Development
Table Hualan Company Details
Table Hualan Meningitis Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Hualan Recent Development
Table Zhejiang Tianyuan Company Details
Table Zhejiang Tianyuan Meningitis Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Zhejiang Tianyuan Recent Development
Table Beijing Tiantan Biological Company Details
Table Beijing Tiantan Biological Meningitis Vaccine Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2016-2018)
Table Beijing Tiantan Biological Recent Development
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Meningitis Vaccine Value Chain
Table Typical Suppliers of Key Meningitis Vaccine Raw Material
Table Meningitis Vaccine Customers List
Table Meningitis Vaccine Sales Channels
Table Meningitis Vaccine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
